Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.38B |
| 2 |
NVIDIA
NVDA
|
+$732M |
| 3 |
Amazon
AMZN
|
+$606M |
| 4 |
Walt Disney
DIS
|
+$559M |
| 5 |
AT&T
T
|
+$466M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ATVI
Activision Blizzard
ATVI
|
+$1.41B |
| 2 |
Comcast
CMCSA
|
+$658M |
| 3 |
Boston Scientific
BSX
|
+$650M |
| 4 |
Palo Alto Networks
PANW
|
+$642M |
| 5 |
T-Mobile US
TMUS
|
+$577M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.81% |
| 2 | Healthcare | 2.95% |
| 3 | Financials | 2.19% |
| 4 | Consumer Discretionary | 2.15% |
| 5 | Industrials | 1.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
11876
CALL
Washington Trust Bancorp
WASH
$767M
| $42.1K | ﹤0.01% |
1,300
-2,000
| -61% | -$54.4K |
|
11877
Q32 Bio
QTTB
$451M
| $42.1K | ﹤0.01% |
3,844
-44,996
| -92% | -$658K |
|
11878
Mind CTI
MNDO
$20.6M
| $42K | ﹤0.01% |
21,374
-7,299
| -25% | -$13.9K |
|
11879
CALL
OraSure Technologies
OSUR
$265M
| $41.8K | ﹤0.01% |
5,100
-1,500
| -23% | -$9.83K |
|
|
SYBX
11880
DELISTED
Synlogic
SYBX
| $41.8K | ﹤0.01% |
+10,860
| New | +$27.5K |
|
11881
Lucid Diagnostics
LUCD
$197M
| $41.8K | ﹤0.01% |
29,639
-6,736
| -19% | -$8.88K |
|
11882
Eledon Pharmaceuticals
ELDN
$288M
| $41.8K | ﹤0.01% |
+23,208
| New | +$32.3K |
|
11883
PUT
Brown-Forman Class A
BF.A
$13.3B
| $41.7K | ﹤0.01% |
700
-3,900
| -85% | -$229K |
|
|
CRESY
11884
PUT
Cresud
CRESY
$750M
| $41.7K | ﹤0.01% |
4,437
-1,225
| -22% | -$10K |
|
11885
PUT
OceanFirst Financial
OCFC
$1.91B
| $41.7K | ﹤0.01% |
2,400
-1,700
| -41% | -$24.8K |
|
11886
CALL
HUTCHMED
HCM
$2.12B
| $41.7K | ﹤0.01% |
2,300
-2,600
| -53% | -$47.3K |
|
11887
PUT
Mizuho Financial
MFG
$132B
| $41.6K | ﹤0.01% |
12,100
+12,000
| +12,000% | +$40.8K |
|
|
OKUR
11888
PUT
OnKure Therapeutics
OKUR
$162M
| $41.6K | ﹤0.01% |
2,600
+2,580
| +12,900% | +$161K |
|
|
AUGX
11889
CALL
DELISTED
Augmedix, Inc. Common Stock
AUGX
| $41.5K | ﹤0.01% |
7,100
-13,600
| -66% | -$71.6K |
|
11890
Modular Medical
MODD
$13.5M
| $41.5K | ﹤0.01% |
+760
| New | +$29.1K |
|
11891
PUT
Viridian Therapeutics
VRDN
$2.5B
| $41.4K | ﹤0.01% |
1,900
-28,600
| -94% | -$451K |
|
11892
PUT
BigBear.ai
BBAI
$1.57B
| $41.3K | ﹤0.01% |
19,300
+4,700
| +32% | +$7.61K |
|
11893
Exagen
XGN
$161M
| $41.3K | ﹤0.01% |
+20,735
| New | +$35.9K |
|
11894
CALL
Summit Therapeutics
SMMT
$10.6B
| $41.2K | ﹤0.01% |
+15,800
| New | +$32.5K |
|
11895
PUT
Avita Medical
RCEL
$243M
| $41.2K | ﹤0.01% |
3,000
-14,800
| -83% | -$170K |
|
11896
CALL
iShares Select U.S. REIT ETF
ICF
$2.12B
| $41.1K | ﹤0.01% |
700
-6,400
| -90% | -$338K |
|
11897
Cardiff Oncology
CRDF
$74.9M
| $41.1K | ﹤0.01% |
+27,760
| New | +$33.6K |
|
|
XELA
11898
DELISTED
Exela Technologies, Inc. Common Stock
XELA
| $41.1K | ﹤0.01% |
+12,227
| New | +$40.6K |
|
11899
CALL
Cambria Tail Risk ETF
TAIL
$146M
| $41K | ﹤0.01% |
3,200
+2,500
| +357% | +$32K |
|
11900
Ametek
AME
$58.4B
| $40.9K | ﹤0.01% |
248
-204,830
| -100% | -$31.2M |
|
Similar funds
Ken Griffin's Q4 2023 Portfolio in Review
As of Q4 2023, Ken Griffin held 15,795 positions worth $500B, up 7.2% from $467B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Ken Griffin withdrew a net $25.4B in Q4 2023, closing 1,624 positions and reducing 6,315 holdings. Its most notable exit was Activision Blizzard, an estimated $1.41B position sold in full.
By sector, the portfolio is most concentrated in Technology at 3.8% of assets, down from 3.9% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Ken Griffin opened a new position in iShares iBoxx $ Investment Grade Corporate Bond ETF worth $129M.
- Ken Griffin's largest Q4 2023 buy was iShares iBoxx $ Investment Grade Corporate Bond ETF: 1,167,658 shares worth $129M.
- Ken Griffin added most to State Street SPDR S&P 500 ETF Trust in Q4 2023, an estimated $1.38B increase.
- Ken Griffin's biggest Q4 2023 reduction was Comcast, cutting an estimated $658M.
- Ken Griffin fully exited Activision Blizzard in Q4 2023, selling an estimated $1.41B.
- Ken Griffin's ten largest holdings make up 31% of its $500B portfolio in Q4 2023.
- Ken Griffin opened 1,585 new positions and closed 1,624 in Q4 2023.
- Ken Griffin's portfolio value rose 7.2% quarter-over-quarter to $500B.
Based on Citadel Advisors's 13F filing for Q4 2023, filed 14 Feb 2024.